6.84 USD
▼+0.45-1.44%
盘后 6.48 0.00%
2026-08-03
市值
$321.65M
市盈率
14.82
EPS
0.43
股息率
0.38%
52 周区间
5.98 – 9.00
成交量
1.23K
Beta
0.61
目标价
—
52W 低 5.9852W 高 9.00
价格走势
公司简介
Clinuvel Pharmaceuticals Limited, a biopharmaceutical company, focuses on developing and commercializing treatments for patients with genetic, metabolic, systemic, and life-threatening disorders in Australia, Europe, the United States, Switzerland, and internationally. Its lead drug candidate is SCENESSE, a systemic photoprotective drug for the prevention of phototoxicity in adult patients with erythropoietic protoporphyria (EPP). The company’s pipeline products include CUV9900, an alpha-melanocyte stimulating hormone analogue; and PRÉNUMBRA, a...